Invitrogen™ Kit ELISA human amyloid beta (agregated)

Ref.: BL-RE-106174Manufacturer ref.: KHB3491 96 tests
€804.00 excl. VAT

L-ELISA d-aggregates human beta-amyloid quantifies human Aβ aggregates in tissue homogenate, ventricular fluid, LCR, tissue culture supernatant and human buffered solution. The dosage will recognize exclusively...

Accession number
P05067
Dose range
0.09-5.7 ng/ml
Sensitivity of the dosage
<0,01 ng
Concentration
0.09 to 5.7 ng/ml
Conjugate
Biotin
Brand
Invitrogen

L-ELISA d-aggregates human beta-amyloid quantifies human Aβ aggregates in tissue homogenate, ventricular fluid, LCR, tissue culture supernatant and human buffered solution. The dosage will recognize exclusively...

L-ELISA d-aggregates human beta-amyloid quantifies human Aβ aggregates in tissue homogenate, ventricular fluid, LCR, tissue culture supernatant and human buffered solution. The dosage will recognize only the natural and recombinant human aggregate Aβ. Principle of the L-ELISA solid phase sandwich human aggregate d-Aβ (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.

Beta-amyloid is a 40–43 amino acid peptide cleavage of the amyloid precursor protein and a putative gamma-secretase. The amyloid beta (1-40) and the amyloid beta (1-42) are two major C-terminal variants of the amyloid beta protein, making up the majority of the amyloid beta proteins. Alloforms beta amyloids (40) and beta amyloids (42) are major components of extracellular plaques present in the brain tissue of Alzheimer's disease. Order information

Shipping conditions: Wet ice

Measurement range

Dose range: 0.09-5.7 ng/ml.

Duration of dosing

Total duration of dosing: 4 hours.

Reproducibility

Coefficient of variation between doses 7.4%, interdose 7.4%.

Target

Target: Human.

Samples

Sample type: Tissue homogenates, Cephal-rachidial liquid, Ventricular liquid, Surnatant (volume Cephalachidian liquid, 100 μl; supernatant, 50 μl; tissue homogenate, 50 μl; ventricular liquid, 100 μl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)10766743
Specifications
Accession numberP05067
Dose range0.09-5.7 ng/ml
Sensitivity of the dosage<0.01 ng
Concentration0.09 to 5.7 ng/ml
ConjugateBiotin
Product typeKit ELISA
Type of sampleTissue homogenates, Cephal-rachid liquid, Ventricular liquid, Surnatant
Target speciesHuman
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)351
Gene symbol(s)AAA,ABETA,ABPP,AD1I,CTFgamma,CVAP,PN-II,PN2,APP
Incubation time4 h
Coefficient of inter-dose variation7.4%
Coefficient of intra-dose variation7.4%
Contents of kits96-well pre-coated plate, Streptavidine HRP, HRP diluent, Wash pad, Chromogen, Stop solution, Adhesive plate covers
Marker or dyeHRP
Genetic markerAggregate Aβ
Quantity96 tests
Regulatory statusRUO
TargetHuman
Test time1 h 20 min
Physical characteristics
Volume of sampleCephalachidian liquid, 100 μl; supernatant, 50 μl; tissue homogenate, 50 μl; ventricular liquid, 100 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h

Origin and customs

Manufacturer ref.KHB3491
Country of originAutriche
HS customs code3002 15 00 00
A question or a specific configuration?
Contact us for a quote.